DrugAug 5, 2020
Allergan PLC Skin Medica Acne System, Contains: Purifying Foaming Wash recall — FDA D-1410-2020
SUBPOTENT DRUG: Products failed assay results at the 12 and 24 month timepoints.
Class IIIFDA: TerminatedAllergan PLC
Recall history in this database
Classification mix: Class I: 16, Class III: 5, Class II: 2.
Medical DeviceDec 25, 2019
Allergan PLC Natrelle Silicone Filled Breast Implants for the following Styles and Sizes recall — FDA Z-0700-2020
The firm has became aware that 2D barcodes on breast implants and sizers may be unreadable by GS-1 configured scanners. These 2D barcodes contain a group separators between fixed-length…
Class IIIFDA: TerminatedAllergan PLC
Medical DeviceDec 25, 2019
Allergan PLC Natrelle Saline-Filled Breast Implant, for the following Styles and sizes recall — FDA Z-0699-2020
The firm has became aware that 2D barcodes on breast implants and sizers may be unreadable by GS-1 configured scanners. These 2D barcodes contain a group separators between fixed-length…
Class IIIFDA: TerminatedAllergan PLC
Medical DeviceDec 25, 2019
Allergan PLC Natrelle Inspira Sillicone-Filled Breast Implants for the following Styles and recall — FDA Z-0701-2020
The firm has became aware that 2D barcodes on breast implants and sizers may be unreadable by GS-1 configured scanners. These 2D barcodes contain a group separators between fixed-length…
Class IIIFDA: TerminatedAllergan PLC
Medical DeviceDec 25, 2019
Allergan PLC NATRELLE Resterilizable Sizers for the styles and sizes: Style 15, Style 20 recall — FDA Z-0702-2020
The firm has became aware that 2D barcodes on breast implants and sizers may be unreadable by GS-1 configured scanners. These 2D barcodes contain a group separators between fixed-length…
Class IIIFDA: TerminatedAllergan PLC
Medical DeviceDec 11, 2019
Allergan PLC XEN Gel Stent, REF 5513-001(US Model), Sterile, RX Only, (01)10888628032439 recall — FDA Z-0598-2020
Residual polishing compounds, that are used in the needle sleeve manufacturing process, may be present on the injector needle. The residual polishing compounds could transfer to the…
Class IIFDA: OngoingAllergan PLC
Medical DeviceSep 18, 2019
Allergan PLC Natrelle, Saline-Filled Breast Implant Biocell Full Height with Fill Tube recall — FDA Z-2451-2019
The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma…
Class IFDA: OngoingAllergan PLC
Medical DeviceSep 18, 2019
Allergan PLC Natrelle133 Plus Tissue Expander With/Without Suture Tabs, BioCell Full Height recall — FDA Z-2456-2019
The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma…
Class IFDA: OngoingAllergan PLC
Medical DeviceSep 18, 2019
Allergan PLC Komuro, Soft Touch, BIOCELL, INTRASHIEL, BioDIMENSIONAL breast implants, Styles recall — FDA Z-2463-2019
The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma…
Class IFDA: OngoingAllergan PLC
Medical DeviceSep 18, 2019
Allergan PLC Natrelle 150 Full Height and Short Height Implants, BIOCELL, INTRASHIEL recall — FDA Z-2465-2019
The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma…
Class IFDA: OngoingAllergan PLC
Medical DeviceSep 18, 2019
Allergan PLC Natrelle and McGhan 410 TruForm 2 (Soft Touch) BIOCELL breast implant, Styles recall — FDA Z-2460-2019
The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma…
Class IFDA: OngoingAllergan PLC
Medical DeviceSep 18, 2019
Allergan PLC Natrelle Inspira, Silicone-Filled Breast Implants, Sterile, for the following recall — FDA Z-2453-2019
The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma…
Class IFDA: OngoingAllergan PLC
Medical DeviceSep 18, 2019
Allergan PLC Natrelle and McGhan Silicone-Filled Breast Implants, TruForm 2 (Soft Touch) recall — FDA Z-2462-2019
The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma…
Class IFDA: OngoingAllergan PLC
Medical DeviceSep 18, 2019
Allergan PLC McGhan Croissant-Shaped Tissue Expanders, Style 134 Product Usage: intended for recall — FDA Z-2458-2019
The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma…
Class IFDA: OngoingAllergan PLC
Medical DeviceSep 18, 2019
Allergan PLC Natrelle and McGhan Silicone-Filled Breast Implant BioCell Round Moderate recall — FDA Z-2454-2019
The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma…
Class IFDA: OngoingAllergan PLC
Medical DeviceSep 18, 2019
Allergan PLC Natrelle 133 Tissue Expanders w/Suture Tabs BIOCELL Full Height Variable recall — FDA Z-2457-2019
The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma…
Class IFDA: OngoingAllergan PLC
Medical DeviceSep 18, 2019
Allergan PLC Natrelle 133 Tissue Expanders recall — FDA Z-2455-2019
The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma…
Class IFDA: OngoingAllergan PLC
Medical DeviceSep 18, 2019
Allergan PLC Natrelle 410, Highly Cohesive Anatomically Shaped Silicone-Filled Breast recall — FDA Z-2452-2019
The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma…
Class IFDA: OngoingAllergan PLC
Medical DeviceSep 18, 2019
Allergan PLC Natrelle 510, TruForm, Dual-Gel, BIOCELL, Styles LX, MX, FX Product Usage recall — FDA Z-2461-2019
The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma…
Class IFDA: OngoingAllergan PLC
Medical DeviceSep 18, 2019
Allergan PLC McGhan BioDIMENSIONAL silicone-Filled Breast Implants, style 153 Product Usage recall — FDA Z-2459-2019
The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma…
Class IFDA: OngoingAllergan PLC
Medical DeviceSep 18, 2019
Allergan PLC RITZ PRINCESS, BIOCELL, INTRASHIEL, BioDIMENSIONAL Breast Implant, Styles RML recall — FDA Z-2464-2019
The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma…
Class IFDA: OngoingAllergan PLC
DrugJan 16, 2019
OZURDEX recall — FDA D-0387-2019
GMP Deviations: A silicone particulate was noted in Ozurdex.
Class IIFDA: CompletedAllergan, PLC.
DrugJun 20, 2018
TAYTULLA Allergan Taytulla Softgel Capsules, 1 mg/20 mcg, 6x28 blister card Physicians's recall — FDA D-0875-2018
Contraceptive Tablets Out of Sequence.
Class IFDA: TerminatedAllergan, PLC.
Understanding this recall history
This page summarizes recall records in which the official source identifies Allergan, PLC. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.